AngioGenix

BiotechnologySeries DBurlingame, US

Latest round

Series D

Last raised

Jan 2005

Total raised

$4.1M

Investors

4

About AngioGenix

Based in California, US, AngioGenex, Inc. operates as a biotechnology company that develops treatments for peripheral and cardiac ischemia.

Who invested in AngioGenix

4 investors across 1 round

See all investors in AngioGenix

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Jan 13, 2005

    Amount

    $4.1M

    Investors

    Locked

Questions about AngioGenix

Who invested in AngioGenix?

AngioGenix has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has AngioGenix raised?

AngioGenix has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did AngioGenix last raise money?

AngioGenix's most recent round on record is a Series D, in Jan 2005.

What does AngioGenix do?

Based in California, US, AngioGenex, Inc.

Where is AngioGenix headquartered?

AngioGenix is headquartered in Burlingame, US.

Which VCs invest in companies like AngioGenix?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AngioGenix's stage. Their profiles are linked below.

Raising like AngioGenix? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.